Caris Life Sciences Announces Partnership with Merck KGaA, Darmstadt, Germany to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development

IRVING, Texas, April 4, 2024 /PRNewswire/ — Caris Discovery™, the therapeutic research arm of Caris Life Sciences® (Caris), the leading next-generation AI TechBio company and precision medicine pioneer, today announced a multi-year strategic partnership with Merck KGaA, Darmstadt,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.